Current methods for assaying angiogenesis in vitro and in vivo

International Journal of Experimental Pathology

Volumn 85, Issue 5, 2004, Pages 233-248

  Staton, Carolyn A ^a   Stribbling, Stephen M ^a   Tazzyman, Simon ^a   Hughes, Russell ^a   Brown, Nicola J ^a   Lewis, Claire E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Angiogenesis; Endothelial; Migration; Proliferation; Tubule; Xenograft

Indexed keywords

ANGIOGENESIS; ASSAY; BLOOD VESSEL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; CORNEA; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; RELIABILITY; REVIEW; TUMOR GROWTH; ZEBRA FISH;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; BIOLOGICAL ASSAY; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRAEMBRYONIC MEMBRANES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN CULTURE TECHNIQUES;

EID: 4844225782     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2004.00396.x     Document Type: Review

References (87)

1. Alessandri G., Raju K., Gullino P.M. (1983) Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res. 43, 1790-1797.
2. Arap R.D., Hagbedorn M., Koivunen E., Pasqualini R., Ruoslahti E. (1998) Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102, 430-437.
3. Auerbach R., Akhtar N., Lewis R.L., Shinners B.L. (2000) Angiogenesis assays: problems pitfalls. Cancer Metastasis Rev. 19, 167-172.
4. Auerbach R. & Auerbach W. (2001) Assays to study angiogenesis. In: Tumor Angiogenesis and Microcirculation. pp. 91-102. (eds. E.E. Voest & P.A. D'Amore). New York: Marcel Dekker.
5. Auerbach R., Auerbach W., Polakowski I. (1991) Assays for angiogenesis: a review. Pharmacol. Ther. 51, 1-11.
6. Auerbach R., Kubai L., Knighton D., Folkman J. (1974) A simple procedure for the long-term cultivation of chicken embryos. Dev. Biol. 41, 391-394.
7. Auerbach R., Lewis R., Shinners B., Kubai L., Aktar N. (2003) Angiogenesis assays: a critical overview. Clin. Chem. 49, 32-40.
8. Bishop E.T., Bell G.T., Bloor S., Broom I.J., Hendry N.K.F., Wheatley D.N. (1999) An in vitro model of angiogenesis: basic features. Angiogenesis 3, 335-344.
9. Brown N.J., Staton C.A., Rodgers G.R., Corke K.P., Underwood J.C.E., Lewis C.E. (2002) Fibrinogen E-fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. Br. J. Cancer 86, 1813-1816.
10. Childs S., Chen J.-N., Garrity D.M., Fishman M.C. (2002) Patterning of angiogenesis in the zebrafish embryo. Development 129, 973-982.
11. Cockerill G.W., Gamble J.R., Vadas M.A. (1995) Angiogenesis: models and modulators. Int. Rev. Cytol. 159, 113-160.
12. Coralli C., Cemazar M., Kanthou C., Tozer G.M., Dachs G.U. (2001) Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res. 61, 4784-4790.
13. Cowen S.E., Bibby M.C., Double J.A. (1995) Characterization of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies. Acta. Oncol. 34, 357-360.
14. Deckers M., van der Plujim G., Dooijewaard S. et al. (2001) Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from foetal mouse bine explants. Lab. Invest. 81, 5-15.
15. Dellian M., Witwer B.P., Salehi H.A., Yuan F., Jain R.K. (1996) Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol. 149, 59-72.
16. Denizot F. & Lang R. (1986) Rapid colormetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89, 271-277.
17. Dings R.P.M., Yokoyama Y., Ramakrishnan S., Griffioen A.W., Mayo K.H. (2003) The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Cancer Res. 63, 382-385.
18. Donovan D., Brown N.J., Bishop E.T., Lewis C.E. (2001) Comparison of the three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 4, 113-121.
19. Dudar T.E., & Jain R.K. (1983) Microcirculatory flow changes during tissue growth. Microvasc. Res. 25, 1-21.
20. Ensoli B., Markham P., Kao V. et al. (1994) Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J. Clin. Invest. 94, 1736-1746.
21. Fajardo L.F., Kwan H.H., Kowalski J., Prionas S.D., Allison A.C. (1992) Dual role of tumour necrosis factor-alpha in angiogenesis. Am. J. Pathol. 140, 539-544.
22. Falk W., Goodwin R.H., Leonard E.J., Leonard E.J. Jr. (1980) A 48-well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33, 239-247.
23. Fan T.-P. & Polverini P.J. (1997) In vivo models of angiogenesis. In: Tumor Angiogenesis. pp. 5-18. (Eds. R. Bicknell, C.E. Lewis & N. Ferrara). Oxford: Oxford University Press.
24. Fawcett J. (1994) Molecular aspects of tumor angiogenesis and metastasis. DPhil Thesis, University of Oxford, Oxford.
25. Folkman J. (1975) Tumor angiogenesis. Adv. Cancer Res. 43, 175-203.
26. Fox S.B., Leek R.D., Weekes M.P., Whitehouse R.M., Gatter K.C., Harris A.L. (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J. Pathol. 177, 275-283.
27. Freshney R.I. (1994) Culture of Animal Cells, 3rd edn. New York: Wiley-Lisds.
28. Fujioka S., Sclabas G.M., Schmidt C. et al. (2003) Function of nuclear factor κB in pancreatic cancer metastasis. Clin. Cancer Res. 9, 346-354.
29. Gagnon E., Cattaruzzi P., Griffith M. et al. (2002) Human vascular endothelial cells with extended life spans: in vitro cell response, protein expression and angiogenesis. Angiogenesis. 5, 21-33.
30. Gerlowski L. & Jain R.K. (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31, 28-305.
31. Gimbrone M.A.J., Cotran R.S., Leapman S.B., Folkman J. (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst. 52, 413-427.
32. Gomez D. & Reich N.C. (2003) Stimulation of primary human endothelial cell proliferation by IFN. J. Immunol. 170, 5373-5381.
33. Gumkowski F., Kaminski G., Kaminski M., Morisset L.M., Auerbach R. (1987) Heterogeneity of mouse vascular endothelium: in vitro studies of lymphatic, large blood vessel and microvascular endothelial cells. Blood Vessels 24, 11-23.
34. Hartwell D.W., Butterfield C.E., Frenette P.S. et al. (1998) Angiogenesis in P- and E-selectin-deficient mice. Microcirculation 5, 173-178.
35. Huffman R.M. (2002) Green fluorescent protein imaging of tumor growth, metastasis, and angiogenesisin mouse models. Lancet Oncol. 3, 546-556.
36. Hu D.E., Hiley C.R., Smither R.L., Gresham G.A., Fan T.P. (1995) Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers. Lab. Invest. 72, 601-610.
37. Inoue K., Chikazawa M., Fukata S., Yoshikawa C., Shuin T. (2003) Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. Clin. Cancer Res. 9, 886-899.
38. Isogai S., Horiguchi M., Weinstein B.M. (2001) The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev. Biol. 230, 278-301.
39. Jackson C.J. & Nguyen M. (1997) Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int. J. Biochem. Cell. Biol. 29, 1167-1177.
40. Jain R.K. (1997) Landis award lecture: delivery of molecular and cellular medicine to solid tumors. Microcirculation 4, 1-21.
41. Jain R.K., Schlenger K., Hockel M., Yuan F. (1997) Quantitative angiogenesis assays: progress and problems. Nat. Med. 3, 1203-1208.
42. Jung S.P., Siegrist B., Wade M.R., Anthony C.T., Woltering E.A. (2001) Inhibition of human angiogenesis with heparin and hydrocortisone. Angiogenesis. 4, 175-186.
43. Kanzawa S., Endo H., Shioya N. (1993) Improved in vitro angiogenesis model by collagen density reduction and the use of type III collagen. Ann. Plast. Surg. 30, 244-251.
44. Lawley T.J. & Kubota Y. (1989) Induction to morphologic differentiation of endothelial cells in culture. J. Invest. Dermatol. 93, 59S-61S.
45. Lawson N.D. & Weinstein B.M. (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307-318.
46. Leunig M., Yuan F., Menger M.D. et al. (1992) Angiogenesis, microvasculature architecture, micro-hemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 52, 6553-6560.
47. Levasseur J.E., Wei E.P., Raper A.J., Kontos H.A., Patterson J.J.L. (1975) Detailed description of a cranial window technique for acute and chronic experiments. Stroke 6, 308-317.
48. Liekens S., De Clerk E., Neyts J. (2001) Angiogenesis: regulators and clinical applications. Biochem. Pharmacol. 61, 253-270.
49. Mahadevan V., Hart I.R., Lewis G.P. (1989) Factors influencing blood supply in wound granuloma quantitated by a new in vivo technique. Cancer Res. 49, 415-419.
50. McCann J. (2001) Jellyfish protein gives new glow to tumor imaging. J. Natl. Cancer Inst. 93, 976-977.
51. Montesano R., Pepper M.S., Orci L. (1993) Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J. Cell Sci. 105, 1013-1024.
52. Morioka H., Weissbach L., Vogel T. et al. (2003) Angiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin. Cancer Res. 9, 1211-1217.
53. Muthukkaruppan V.R. & Auerbach R. (1979) Angiogenesis in the mouse cornea. Science 205, 1416-1418.
54. Muthukkaruppan V.R., Shinneers B.L., Lewis R., Park S.-J., Baechler B.J., Auerbach R. (2000) The chick embryo aortic arch assay: a new, rapid, quantifiable in vitro method for testing the efficacy of angiogenic and anti-angiogenic factors in a three-dimensional, serum-free organ culture system. Proc. Am. Assoc. Cancer. Res. 41, 65.
55. Nehls V. & Drenckhahn D. (1995) A Novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res. 50, 311-322.
56. Nguyen M., Shing Y., Folkman J. (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47, 31-40.
57. Nicosia R.F., Bonanno E., Smith M. (1993) Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J. Cell Physiol. 154, 654-661.
58. Nicosia R.F., Lin Y.J., Hazelton D., Qian X. (1997) Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am. J. Pathol. 151, 1379-1386.
59. Nicosia R.F. & Ottinetti A. (1990) Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115-122.
60. Obeso J.L. & Auerbach R. (1984) A new microtechnique for quantitating cell movement in vitro using polystyrene bead monolayers. J. Immunol. Methods 70, 141-152.
61. Oikawa T., Sasaki M., Inose M. et al. (1997) Effect of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. Anticancer Res. 17, 1881-1886.
62. Passaniti A., Taylor R.M., Pili R. et al. (1992) A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528.
63. Pepper M.S., Belin D., Montesano R., Orci L., Vassali J.D. (1990) Transforming growth factor-beta 1 modulated basic fibroblast growth factor induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111, 743-755.
64. Plunkett M.L. & Hailey J.A. (1990) An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab. Invest. 62, 510-517.
65. Presta M., Rusnati M., Belleri M., Morbidelli L., Ziche M., Ribatti D. (1999) Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenic process. Cancer Res. 59, 2417-2424.
66. Ribatti D. & Vacca A. (1999) Models for studying angiogenesis in vivo. Int. J. Biol. Markers 14, 207-213.
67. Ribatti D., Vacca A., Roncali L., Dammacco F. (1996) The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int. J. Dev. Biol. 40, 1189-1197.
68. Rubinstein A.L. (2003) Zebrafish: from disease modelling to drug discovery. Curr. Opin. Drug Discov. Devel. 6, 218-223.
69. Sakuda H., Nakashima Y., Kuriyama S., Sueishi K. (1992) Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1. Am. J. Pathol. 141, 1507-1516.
70. Sanz L., Pascual M., Munoz A., Gonzalez M.A., Alvador C.H., Alvarez-Vallina L. (2002) Development of a computer-assisted high-throuhgput screening platform for anti-angiogenic therapy. Microvasc. Res. 63, 335-339.
71. Sato N., Sato T., Takahashi S., Kikuchi K. (1986) Establishment of murine endothelial cell lines that develop angiosarcomas in vivo: brief demonstration of a proposed animal model for Kaposi's sarcoma. Cancer Res. 46, 362-366.
72. Semba T., Funahashi Y., Ono N. et al. (2004) An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model: possible value of integrin α2 on platelets as a biological marker. Clin. Cancer Res. 10, 1430-1438.
73. Serbedzija G.N., Flynn E., Willett C.E. (1999) Zebrafish angiogenesis: a new model for drug screening. Angiogenesis 3, 353-359.
74. Staton C.A., Brown N.J., Rodgers G.R. et al. (2004) Alphastatin, a 24 amino-acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood 103, 601-606.
75. Stiffey-Wilusz J., Boice J.A., Ronan J., Fletcher A.M., Anderson M.S. (2001) An ex vivo angiogenesis assay utilizing commercial porcine carotid artery: modification of the rat aortic ring assay. Angiogenesis 4, 3-9.
76. Stribbling S.M., Friedlos F., Martin J. et al. (2000) Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect. Hum. Gene Ther. 11, 285-292.
77. Taylor C.M. & Weiss J.B. (1984) The chick vitelline membrane as a test system for angiogenesis and antiangiogenesis. Int. J. Microcirc. Clin. Exp. 3, 337. (abstract).
78. Tercel M., Stribbling S.M., Sheppard H. et al. (2003) Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores. J. Med. Chem. 46, 2132-2151.
79. Wemme H., Pfeifer S., Heck R., Muller-Quernheim J. (1992) Measurement of lymphocyte proliferation: critical analysis of radioactive and photometric methods. Immunobiology 185, 78-89.
80. Yang M., Baranov E., Jiang P. et al. (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc. Natl. Acad. Sci. USA 97, 1206-1211.
81. Yang M., Baranov E., Li X.-M. et al. (2001) Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc. Natl. Acad. Sci. USA 98, 2616-2621.
82. Yang M., Baranov E., Wang J.-W. et al. (2002) Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc. Natl. Acad. Sci. USA 99, 3824-3829.
83. Yonekura K., Basaki Y., Chikahisa L. et al. (1999) UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin. Cancer Res. 5, 2185-2191.
84. Yuan F., Salehi H.A., Boucher Y., Vasthare U.S., Tuma R.F., Jain R.K. (1994) Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54, 4564-4568.
85. Zetter B.R. (1987) Assay of capillary endothelial cell migration. Methods Enzymol. 147, 135-144.
86. Zhong T., Childs S., Liu J.P., Fishman M.C. (2001) Gridlock Signalling Pathway Fashions the first embryonic artery. Nature 414, 216-220.
87. Zimrin A.B., Villeponteau B., Macaig T. (1995) Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem. Biophys. Res. Commun. 213, 630-638.